Dispensing opioid substitution treatment: Practices, attitudes and intentions of community-based pharmacists

Drug and Alcohol Review

Volumn 27, Issue 1, 2008, Pages 47-53

  Lawrinson, Peter ^a,c   Roche, Ann ^a   Terao, Hiroe ^a   Le, Phuong Phi ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b Drug and Alcohol Services ^*

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Community pharmacy; Methadone maintenance; Opioid substitution treatment; Pharmacist attitudes; Treatment intentions

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC AGENT;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; AUSTRALIA; DEMOGRAPHY; FEMALE; HEALTH CARE DELIVERY; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; MIDDLE AGED; OPIATE ADDICTION; PHARMACIST; PHARMACY; PROFESSIONAL PRACTICE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; STATISTICS; TELEPHONE;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; BUPRENORPHINE; COMMUNITY PHARMACY SERVICES; DELIVERY OF HEALTH CARE; DEMOGRAPHY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; PHARMACISTS; PROFESSIONAL PRACTICE LOCATION; QUESTIONNAIRES; SOUTH AUSTRALIA; TELEPHONE;

EID: 36549004938     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230701710852     Document Type: Article

References (17)

1. Australian Institute of Health and Welfare (AIHW). Alcohol and other drug treatment services in Australia 2004-05: report on the national minimum data set, Drug Treatment Series 5. AIHW cat. no. HSE 43. Canberra: AIHW, 2006.
2. Australian Institute of Health and Welfare (AIHW). Alcohol and other drug treatment services in Australia 2001-02: report on the national minimum data set, Drug Treatment Series 2. AIHW cat. no. HSE 28. Canberra: AIHW, 2003.
3. Matheson C, Bond CM, Pitcairn J. Community pharmacy services for drug misusers in Scotland: what difference does 5 years make? Addiction 2002;97:1405-11.
4. Hurley M. Guide for pharmacists: addiction treatment and maintenance pharmacotherapy (methadone and buprenorphine) programs in South Australia. Parkside: Drug and Alcohol Services Council, Government of South Australia, 2004.
5. Healthcare Management Advisors. Development, implementation and evaluation of funding model options for the dispensing of pharmacotherapies for opioid dependence in community pharmacy. Pharmacy Guild of Australia, Unpublished document, 2003.
6. Hotham E, Roche A, Skinner N, Dollman B. The general practitioner pharmacotherapy prescribing workforce: examining sustainability from a systems perspective. Drug Alcohol Rev 2005;24:1-8.
7. Muhleisen P, Lintzeris N, Koutroulis G, et al. Evaluation of methadone dispensing in community pharmacies in Victoria. Aust Pharm 1998;17(suppl):7-12.
8. Peterson GM. Drug misuse and harm reduction: pharmacy's magnificent contribution, but at what cost? J Clin Pharm Ther 1999;24:165-9.
9. Le PP, Hotham ED. Exploring the dissonance between business and public health policy: pharmacy and the provision of opioid pharmacotherapies and clean needles in rural settings. Int J Pharm Pract 2006;14:63-70.
10. Australian Bureau of Statistics (ABS). Australian demographic statistics. ABS cat. no. 3101.0, Canberra: ABS, 2004.
11. Berbatis CG, Sunderland VB. The role of community pharmacy in methadone maintenance treatment: an evaluation through a literature review, prospective, retrospective and other studies conducted in Australia and overseas from 1998-2000, Barton: Australian Association of Consultant Pharmacy, 2001.
12. Jesson J, Wilson K, Barton A, Pocock R. Exploring the potential for supervised methadone consumption and shared care contracts with drug misusers. Pharm J 2000;265 (Pharmacy Practice Research Supplement, Sept. 16): R37.
13. SPSS Inc., SPSS release 12.0, Chicago, IL: SPSS Inc., 2003.
14. Sheridan J, Cronin F. Supervised self-administration of methadone at community pharmacies: the introduction of a
15. new service. Pharm J 2002;268:471-4.
16. Muhleisen P, Panjari M, Lee N. Buprenorphine dispensing in a cohort of community pharmacies in Victoria. Aust Pharm 2003;22:229-34.
17. Matheson C, Bond CM, Mollison J. Attitudinal factors associated with community pharmacists' involvement in services for drug misusers. Addiction 1999;94:1349-59.